CHELMSFORD, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Brooks Automation, Inc. (Nasdaq:BRKS), a leading worldwide
provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, today
reported financial results for the third fiscal quarter of 2016, ended June 30, 2016.
Fiscal Third Quarter of 2016 Financial and Operational Highlights:
- Revenue was $147.5 million;
- GAAP Net Income was $8.6 million with diluted EPS of $0.12;
- Non-GAAP Net Income was $11.1 million with diluted EPS of $0.16;
- Cash flow from operations was $15.7 million; and
- Total of Cash, Cash Equivalents, and Marketable Securities, as of June 30, 2016, was $72.2 million.
Summary of GAAP and Non-GAAP Earnings (Losses)
| |
|
|
Quarter
Ended |
| |
|
|
June 30, |
|
March 31, |
|
June 30, |
| Dollars in thousands, except per share data |
|
|
2016 |
|
2016 |
|
2015 |
| GAAP net income (loss) |
|
|
$ |
8,564 |
|
|
$ |
(83,939 |
) |
|
$ |
7,681 |
|
| GAAP diluted earnings (loss) per share |
|
|
$ |
0.12 |
|
|
$ |
(1.22 |
) |
|
$ |
0.11 |
|
| |
|
|
|
|
|
|
|
| Non-GAAP net income |
|
|
$ |
11,128 |
|
|
$ |
4,920 |
|
|
$ |
10,277 |
|
| Non-GAAP diluted earnings per share |
|
|
$ |
0.16 |
|
|
$ |
0.07 |
|
|
$ |
0.15 |
|
A reconciliation of non-GAAP measures to the most nearly comparable GAAP measures follows the consolidated balance
sheets, statements of operations and statements of cash flows included in this release.
Management Comments
“Our strong third quarter performance highlights the strength of our portfolio and the improved earnings power of our revised
organization structure. Sequential growth in automation, contamination control, BioStore systems, and BioStorage services has
supported improved gross margins and cash flow,” commented Steve Schwartz, CEO of Brooks Automation. “Our Life Sciences business
has continued to execute well, with growth coming from both large sample storage systems and BioStorage Technologies
services. Both semiconductor and life sciences segments are on track to yield further growth and improve profits.”
GAAP Summary
Revenue increased 9% sequentially to $147.5 million in the third quarter of fiscal 2016, driven by a 10% increase in Life Sciences
and a 9% increase in Brooks Semiconductor Solutions Group (formerly Brooks Product Solutions and Brooks Global Services). Gross
margin was 36.7%, up 2.1 percentage points from the second fiscal quarter of 2016. Operating expense of $45.7 million was 14%
or $7.5 million less than the previous quarter primarily driven by lower restructuring charges. In the third quarter, the
Company incurred $1.0 million of restructuring charges compared to $7.3 million in the second quarter. The Company had a $0.2
million benefit from the reversal of accrued incentive based compensation for employees separated from the Company, compared to a
$1.7 million similar benefit in the second quarter. GAAP net income was $8.6 million and diluted earnings per share was $0.12.
Beginning in the third quarter, the Company consolidated the operating results of Brooks Product Solutions (BPS)
and Brooks Global Solutions (BGS) into one segment, referred to as Brooks Semiconductor Solutions Group, or BSSG, to better align
with its new organizational structure and to reflect how strategic directions and resources are determined. The Brooks Life
Sciences Systems (BLSS) segment remains unchanged.
Amortization of intangibles, special charges, and one-time items are appropriately included in the GAAP summary of
earnings. The impact on earnings of these items is set out in the unaudited table included with this release.
Results of Q3 Fiscal 2016 (Non-GAAP Discussion)
Non-GAAP net income was $11.1 million in the third quarter, resulting in non-GAAP earnings per share of $0.16. This compares to
non-GAAP net income of $4.9 million and non-GAAP earnings per share of $0.07 in the second quarter, and non-GAAP net income of
$10.3 million and non-GAAP earnings per share of $0.15 in the third quarter of fiscal 2015.
As noted above, revenue for the third fiscal quarter of 2016 was $147.5 million, up 9% compared to the second
fiscal quarter of 2016. The Brooks Semiconductor Solutions Group revenue increased 9% to $118.4 million, primarily driven by sales
of Contamination Control Solutions of $15.8 million, up $9.6 million from the second quarter. Brooks Life Science Systems
revenue grew 10% sequentially to $29.1 million, driven by 11% or $1.6 million sequential growth in the legacy business and 9% or
$1.0 million growth in the recently acquired BioStorage services business, which reached $12.4 million of revenue in the
quarter.
Adjusted gross margin, which excludes amortization, purchase accounting impacts and special charges, was 37.5% in
the third quarter, up 2.2 percentage points from the prior quarter. The Semiconductor Solutions adjusted gross margin was 36.9% in
the third quarter compared to 34.5% in the prior period, with improvements coming from both product and services lines. The
Life Sciences adjusted gross margin was 40.0% in the third quarter compared to 38.5% in the prior period, with the legacy Life
Sciences business delivering improved margins from large store systems. Gross margins for BioStorage Technologies were 43.9%, up
0.4 percentage points. In summary, the total adjusted gross profit increased by $7.6 million compared to the prior quarter, driven
by revenue increases and gross margin improvements across both segments.
Bookings for the Semiconductor Solutions business in the third quarter totaled $115.2 million, compared to $108.6
million in the second quarter. The Life Sciences business booked a total of $40.6 million of new contract value in the
quarter.
Non-GAAP operating expense of $41.8 million decreased $0.7 million sequentially, driven primarily by the
restructuring actions initiated in the second quarter. The operating expense includes a benefit from the reversal of incentive
based compensation accruals for employees departing in this quarter of $0.2 million, compared to $1.6 million in the second fiscal
quarter.
Cash flow from operations was $15.7 million in the quarter and adjusted EBITDA was $19.0 million. The
Company's cash, cash equivalents, and marketable securities increased $3.9 million to $72.2 million as of June 30, 2016, which
reflects the operating cash flow, dividend payment and capital expenditures during the quarter.
Quarterly Cash Dividend
The Company additionally announced that the Board of Directors has approved a dividend of $0.10 per share payable on September 23,
2016 to stockholders of record on September 2, 2016. Future dividend declarations, as well as the record and payment dates for such
dividends, are subject to the final determination of the Company's Board of Directors.
Guidance for Fourth Fiscal Quarter 2016
The Company announced revenue and earnings guidance for the fourth quarter of fiscal 2016. Revenue is expected to be in the range
of $146 million to $151 million and non-GAAP diluted EPS is expected to be in the range of $0.14 to $0.17. (GAAP diluted EPS is
projected to be $0.06 to $0.09, reflecting the impact of amortization, purchase price accounting, and anticipated restructuring
charges.)
Conference Call
Brooks management will webcast its third quarter earnings conference call today at 5:30 p.m. Eastern Time. During the call, Company
management will respond to questions concerning, but not limited to, the Company's financial performance, business conditions and
industry outlook. Management's responses could contain information that has not been previously disclosed.
The call will be broadcast live over the Internet and, together with presentation materials referenced on the call,
will be hosted at the Investor Relations section of Brooks' website at www.brooks.com, and will be archived online on this website
for convenient on-demand replay. In addition, you may call 800-381-7839 (US & Canada only) or 212-231-2900 to listen to the live
webcast.
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor
manufacturing and life sciences. Brooks’ technologies, engineering competencies and global service capabilities provide customers
speed to market and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled
environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market and, by applying
expertise in automation and cryogenics, has expanded its offerings to meet the sample storage needs of customers in the life
sciences industry. Brooks recently completed a strategic acquisition of BioStorage Technologies, Inc., complementing Brooks’ life
sciences offerings with comprehensive outsource services. Brooks now offers, in addition to a broad range of products and
services for on-site infrastructure for sample management in temperatures of -20°C to -150°C, outsource service solutions across
the complete life cycle of biological samples including collection, transportation, processing, storage, protection, retrieval and
disposal. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more
information, visit www.brooks.com.
“Safe Harbor Statement” under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These
statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause
Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management
at the time they are made. These forward-looking statements include statements regarding our revenue and operating margin
expectations, our ability to develop further our business in new and adjacent markets, and our ability to achieve financial success
in the future. Factors that could cause results to differ from our expectations include the following: volatility of the industries
the Company serves, particularly the semiconductor industry; our possible inability to meet demand for our products due to
difficulties in obtaining components and materials from our suppliers in required quantities and of required quality; the inability
of customers to make payments to us when due; the timing and effectiveness of cost reduction and cost control measures; price
competition; disputes concerning intellectual property; continuing uncertainties in global political and economic conditions, and
other factors and other risks that we have described in our filings with the Securities and Exchange Commission, including but not
limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. As a result we can
provide no assurance that our future results will not be materially different from those projected. Brooks expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our
expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no
obligation to update the information contained in this press release.
CONTACTS:
Lynne
Yassemedis
Brooks Automation
978.262.2400
lynne.yassemedis@brooks.com
John Mills
Partner
ICR, LLC
646.277.1254
john.mills@icrinc.com
| BROOKS AUTOMATION, INC. |
| CONSOLIDATED BALANCE SHEETS |
| (unaudited) |
| (In thousands, except share and per share data) |
| |
| |
June 30,
2016 |
|
September 30,
2015 |
| Assets |
|
|
|
| Current assets |
|
|
|
| Cash and cash equivalents |
$ |
66,116 |
|
|
$ |
80,722 |
|
| Marketable securities |
18 |
|
|
70,021 |
|
| Accounts receivable, net |
101,091 |
|
|
86,448 |
|
| Inventories |
98,157 |
|
|
100,619 |
|
| Deferred tax assets |
3,958 |
|
|
17,609 |
|
| Assets held for sale |
2,806 |
|
|
2,900 |
|
| Prepaid expenses and other current assets |
21,078 |
|
|
15,158 |
|
| Total current assets |
293,224 |
|
|
373,477 |
|
| Property, plant and equipment, net |
54,763 |
|
|
41,855 |
|
| Long-term marketable securities |
6,068 |
|
|
63,287 |
|
| Long-term deferred tax assets |
1,125 |
|
|
70,476 |
|
| Goodwill |
202,386 |
|
|
121,408 |
|
| Intangible assets, net |
85,646 |
|
|
55,446 |
|
| Equity method investments |
26,530 |
|
|
24,308 |
|
| Other assets |
12,579 |
|
|
9,397 |
|
| Total assets |
$ |
682,321 |
|
|
$ |
759,654 |
|
| Liabilities and Stockholders' equity |
|
|
|
| Current liabilities |
|
|
|
| Accounts payable |
$ |
41,502 |
|
|
$ |
44,890 |
|
| Deferred revenue |
25,522 |
|
|
17,886 |
|
| Accrued warranty and retrofit costs |
5,955 |
|
|
6,089 |
|
| Accrued compensation and benefits |
18,031 |
|
|
20,401 |
|
| Accrued restructuring costs |
5,789 |
|
|
2,073 |
|
| Accrued income taxes payable |
7,168 |
|
|
6,111 |
|
| Deferred tax liabilities |
331 |
|
|
1,251 |
|
| Accrued expenses and other current liabilities |
17,751 |
|
|
15,550 |
|
| Total current liabilities |
122,049 |
|
|
114,251 |
|
| Long-term tax reserves |
2,714 |
|
|
3,644 |
|
| Long-term deferred tax liabilities |
6,962 |
|
|
3,196 |
|
| Long-term pension liabilities |
3,212 |
|
|
3,118 |
|
| Other long-term liabilities |
4,329 |
|
|
3,400 |
|
| Total liabilities |
139,266 |
|
|
127,609 |
|
| Commitments and contingencies |
|
|
|
| Stockholders' equity |
|
|
|
| Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or
outstanding |
— |
|
|
— |
|
| Common stock, $0.01 par value, 125,000,000 shares authorized, 82,097,858 shares issued and
68,635,989 shares outstanding at June 30, 2016; 81,093,052 shares issued and 67,631,183 shares outstanding at
September 30, 2015 |
821 |
|
|
811 |
|
| Additional paid-in capital |
1,851,292 |
|
|
1,846,357 |
|
| Accumulated other comprehensive income |
12,598 |
|
|
5,898 |
|
| Treasury stock at cost- 13,461,869 shares |
(200,956 |
) |
|
(200,956 |
) |
| Accumulated deficit |
(1,120,700 |
) |
|
(1,020,065 |
) |
| Total stockholders' equity |
543,055 |
|
|
632,045 |
|
| Total liabilities and stockholders' equity |
$ |
682,321 |
|
|
$ |
759,654 |
|
| |
| BROOKS AUTOMATION, INC. |
| CONSOLIDATED STATEMENTS OF OPERATIONS |
| (unaudited) |
| (In thousands, except per share data) |
| |
| |
Three Months Ended
June 30, |
|
Nine Months Ended
June 30, |
| |
2016 |
|
2015 |
|
2016 |
|
2015 |
| Revenue |
|
|
|
|
|
|
|
| Product |
$ |
111,596 |
|
|
$ |
120,816 |
|
|
$ |
302,238 |
|
|
$ |
336,941 |
|
| Services |
35,938 |
|
|
24,078 |
|
|
100,532 |
|
|
70,002 |
|
| Total revenue |
147,534 |
|
|
144,894 |
|
|
402,770 |
|
|
406,943 |
|
| Cost of revenue (a) |
|
|
|
|
|
|
|
| Product |
69,557 |
|
|
77,128 |
|
|
192,816 |
|
|
221,877 |
|
| Services |
23,814 |
|
|
16,579 |
|
|
68,437 |
|
|
48,766 |
|
| Total cost of revenue |
93,371 |
|
|
93,707 |
|
|
261,253 |
|
|
270,643 |
|
| Gross profit |
54,163 |
|
|
51,187 |
|
|
141,517 |
|
|
136,300 |
|
| Operating expenses |
|
|
|
|
|
|
|
| Research and development |
12,819 |
|
|
12,834 |
|
|
39,208 |
|
|
39,001 |
|
| Selling, general and administrative |
31,854 |
|
|
27,825 |
|
|
98,667 |
|
|
86,845 |
|
| Restructuring and other charges |
996 |
|
|
358 |
|
|
9,807 |
|
|
3,711 |
|
| Total operating expenses |
45,669 |
|
|
41,017 |
|
|
147,682 |
|
|
129,557 |
|
| Operating income (loss) |
8,494 |
|
|
10,170 |
|
|
(6,165 |
) |
|
6,743 |
|
| Interest income |
55 |
|
|
199 |
|
|
310 |
|
|
678 |
|
| Interest expense |
(37 |
) |
|
(100 |
) |
|
(56 |
) |
|
(300 |
) |
| Other (loss) income, net |
(107 |
) |
|
460 |
|
|
(289 |
) |
|
2,640 |
|
| Income (loss) before income taxes and equity in earnings (losses) of equity method
investments |
8,405 |
|
|
10,729 |
|
|
(6,200 |
) |
|
9,761 |
|
| Income tax provision |
220 |
|
|
3,340 |
|
|
75,070 |
|
|
1,790 |
|
| Income (loss) income before equity in earnings (losses) of equity method
investments |
8,185 |
|
|
7,389 |
|
|
(81,270 |
) |
|
7,971 |
|
| Equity in earnings (losses) of equity method investments |
379 |
|
|
292 |
|
|
1,248 |
|
|
(313 |
) |
| Net income (loss) |
8,564 |
|
|
7,681 |
|
|
(80,022 |
) |
|
7,658 |
|
| Basic net income (loss) per share |
$ |
0.12 |
|
|
$ |
0.11 |
|
|
$ |
(1.17 |
) |
|
$ |
0.11 |
|
| Diluted net income (loss) per share |
$ |
0.12 |
|
|
$ |
0.11 |
|
|
$ |
(1.17 |
) |
|
$ |
0.11 |
|
| Dividend declared per share |
$ |
0.10 |
|
|
$ |
0.10 |
|
|
$ |
0.30 |
|
|
$ |
0.30 |
|
| |
|
|
|
|
|
|
|
| Weighted average shares outstanding used in computing net (loss) income per
share: |
|
|
|
|
|
|
|
| Basic |
68,628 |
|
|
67,454 |
|
|
68,437 |
|
|
67,321 |
|
| Diluted |
69,166 |
|
|
68,571 |
|
|
68,437 |
|
|
68,520 |
|
| |
|
|
|
|
|
|
|
| (a) Periods ended June 30, 2016 on a year-to-date basis and June 30,
2015 on a quarter-to-date and year-to-date basis reflect a reclassification correction between the cost of service revenue and
the cost of product revenue. Please refer to the Form 10-Q for the quarter ended June 30, 2016. |
| |
| BROOKS AUTOMATION, INC. |
| CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (unaudited) |
| (In thousands) |
| |
| |
Nine months ended June
30, |
| |
2016 |
|
2015 |
| Cash flows from operating activities |
|
|
|
| Net (loss) income |
$ |
(80,022 |
) |
|
$ |
7,658 |
|
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
|
| Depreciation and amortization |
21,320 |
|
|
18,929 |
|
| Stock-based compensation |
8,206 |
|
|
9,510 |
|
| Amortization of premium on marketable securities and deferred financing costs |
368 |
|
|
917 |
|
| Undistributed (earnings) losses of equity method investments |
(1,248 |
) |
|
313 |
|
| Deferred income tax provision (benefit) |
71,875 |
|
|
(2,262 |
) |
| Gain on disposal of long-lived assets |
— |
|
|
(4 |
) |
| Changes in operating assets and liabilities, net of acquisitions: |
|
|
|
| Accounts receivable |
2,862 |
|
|
(19,070 |
) |
| Inventories |
2,110 |
|
|
(1,519 |
) |
| Prepaid expenses and other current assets |
(3,909 |
) |
|
(4,881 |
) |
| Accounts payable |
(4,689 |
) |
|
11,600 |
|
| Deferred revenue |
7,171 |
|
|
(2,339 |
) |
| Accrued warranty and retrofit costs |
(87 |
) |
|
(320 |
) |
| Accrued compensation and benefits |
(6,558 |
) |
|
(1,907 |
) |
| Accrued restructuring costs |
3,720 |
|
|
(660 |
) |
| Accrued expenses and other current liabilities |
(5,010 |
) |
|
5,506 |
|
| Net cash provided by operating activities |
16,109 |
|
|
21,471 |
|
| Cash flows from investing activities |
|
|
|
| Purchases of property, plant and equipment |
(9,414 |
) |
|
(5,945 |
) |
| Purchases of marketable securities |
(12,901 |
) |
|
(58,991 |
) |
| Sales and maturities of marketable securities |
139,388 |
|
|
74,515 |
|
| Disbursement for a loan receivable |
(1,491 |
) |
|
— |
|
| Acquisitions, net of cash acquired |
(125,498 |
) |
|
(17,257 |
) |
| Proceeds from sales of property, plant and equipment |
— |
|
|
6 |
|
| Purchases of other investments |
(500 |
) |
|
(5,000 |
) |
| Net cash used in investing activities |
(10,416 |
) |
|
(12,672 |
) |
| Cash flows from financing activities |
|
|
|
| Proceeds from issuance of common stock |
948 |
|
|
867 |
|
| Principal repayments of capital lease obligations |
— |
|
|
(368 |
) |
| Payment of deferred financing costs |
(508 |
) |
|
— |
|
| Common stock dividends paid |
(20,613 |
) |
|
(20,229 |
) |
| Net cash used in financing activities |
(20,173 |
) |
|
(19,730 |
) |
| Effects of exchange rate changes on cash and cash equivalents |
(126 |
) |
|
(3,513 |
) |
| Net decrease in cash and cash equivalents |
(14,606 |
) |
|
(14,444 |
) |
| Cash and cash equivalents, beginning of period |
80,722 |
|
|
94,114 |
|
| Cash and cash equivalents, end of period |
$ |
66,116 |
|
|
$ |
79,670 |
|
| |
Notes on Non-GAAP Financial Measures:
The information in this press release is for: internal managerial purposes; when publicly providing guidance on future results; and
as a means to evaluate period-to-period comparisons. These financial measures are used in addition to and in conjunction with
results presented in accordance with GAAP and should not be relied upon to the exclusion of GAAP financial measures. Management
believes these financial measures provide an additional way of viewing aspects of our operations, that, when viewed with our GAAP
results and the accompanying reconciliations to the corresponding GAAP financial measures, provide a more complete understanding of
our business. Management strongly encourages investors to review our financial statements and publicly-filed reports in their
entirety and not rely on any single measure.
The press release includes financial measures which exclude the effects of special charges such as restructuring
charges and acquisition related charges. Management believes these measures are useful to investors because it eliminates
accounting charges that do not reflect Brooks' day-to-day operations. Tables reconciling GAAP to the non-GAAP measures are
presented below.
| |
|
|
|
|
Quarter
Ended |
|
|
|
|
| |
June 30,
2016 |
|
March 31,
2016 |
|
June 30,
2015 |
| Dollars in thousands, except per share data |
$ |
|
Per Diluted Share |
|
$ |
|
Per Diluted Share |
|
$ |
|
Per Diluted Share |
| GAAP net (loss) income |
$ |
8,564 |
|
|
$ |
0.12 |
|
|
$ |
(83,939 |
) |
|
$ |
(1.22 |
) |
|
$ |
7,681 |
|
|
$ |
0.11 |
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
| Purchase accounting impact on inventory and contracts acquired |
125 |
|
|
— |
|
|
250 |
|
|
— |
|
|
— |
|
|
— |
|
| Amortization of intangible assets |
3,837 |
|
|
0.06 |
|
|
3,809 |
|
|
0.06 |
|
|
3,216 |
|
|
0.05 |
|
| Restructuring charges |
996 |
|
|
0.01 |
|
|
7,336 |
|
|
0.11 |
|
|
358 |
|
|
0.01 |
|
| Gain on sale of a building |
(55 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
| Liquidation costs due to dissolution of joint venture |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
69 |
|
|
— |
|
| Merger costs |
84 |
|
|
— |
|
|
215 |
|
|
— |
|
|
44 |
|
|
— |
|
| Change in valuation allowance against deferred tax assets |
— |
|
|
— |
|
|
79,340 |
|
|
1.15 |
|
|
— |
|
|
— |
|
| Tax effect of adjustments |
(2,423 |
) |
|
(0.04 |
) |
|
(2,091 |
) |
|
(0.03 |
) |
|
(1,091 |
) |
|
(0.02 |
) |
| Non-GAAP adjusted net income |
11,128 |
|
|
0.16 |
|
|
4,920 |
|
|
0.07 |
|
|
10,277 |
|
|
0.15 |
|
| Stock-based compensation, pre-tax |
1,637 |
|
|
— |
|
|
1,855 |
|
|
— |
|
|
2,402 |
|
|
— |
|
| Tax rate |
20 |
% |
|
— |
|
|
16 |
% |
|
— |
|
|
30 |
% |
|
— |
|
| Stock-based compensation, net of tax (a) |
1,318 |
|
|
0.02 |
|
|
1,556 |
|
|
0.02 |
|
|
1,677 |
|
|
0.03 |
|
| Non-GAAP adjusted net income - excluding stock-based compensation |
$ |
12,446 |
|
|
$ |
0.18 |
|
|
$ |
6,476 |
|
|
$ |
0.09 |
|
|
$ |
11,954 |
|
|
$ |
0.17 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Shares used in computing non-GAAP diluted net (loss) income per share |
— |
|
|
69,166 |
|
|
— |
|
|
69,101 |
|
|
— |
|
|
68,571 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| (a) The tax rate represents the effective tax rate on non-GAAP taxable
ordinary income. We expanded our disclosure to correct and clarify the after tax impact of stock-based compensation on Non-GAAP
adjusted net income and diluted EPS. For additional information on the impact of this correction on prior periods, please refer
to the conference call presentation included in Investor Relations section of the Brooks website at www.brooks.com. |
| |
Nine Months
Ended |
| |
June 30,
2016 |
|
June 30,
2015 |
| Dollars in thousands, except per share data |
$ |
|
Per Diluted Share |
|
$ |
|
Per Diluted Share |
| GAAP net loss |
$ |
(80,022 |
) |
|
$ |
(1.17 |
) |
|
$ |
7,658 |
|
|
$ |
0.11 |
|
| Adjustments: |
|
|
|
|
|
|
|
| Purchase accounting impact on inventory and contracts acquired |
499 |
|
|
0.01 |
|
|
1,511 |
|
|
0.02 |
|
| Amortization of intangible assets |
11,153 |
|
|
0.16 |
|
|
9,646 |
|
|
0.14 |
|
| Impairment of equity method investments |
— |
|
|
— |
|
|
681 |
|
|
0.01 |
|
| Restructuring charges |
9,807 |
|
|
0.14 |
|
|
3,711 |
|
|
0.05 |
|
| Gain on sale of a building |
(55 |
) |
|
— |
|
|
— |
|
|
— |
|
| Liquidation costs due to dissolution of joint venture |
— |
|
|
— |
|
|
69 |
|
|
— |
|
| Merger costs |
3,295 |
|
|
0.05 |
|
|
432 |
|
|
0.01 |
|
| Change in valuation allowance against deferred tax assets |
79,340 |
|
|
1.16 |
|
|
— |
|
|
— |
|
| Tax effect of adjustments |
(6,723 |
) |
|
(0.10 |
) |
|
(4,559 |
) |
|
(0.07 |
) |
| Non-GAAP adjusted net income |
17,294 |
|
|
0.25 |
|
|
19,149 |
|
|
0.28 |
|
| Stock-based compensation, pre-tax |
8,206 |
|
|
— |
|
|
9,510 |
|
|
— |
|
| Tax rate |
24 |
% |
|
— |
|
|
30 |
% |
|
— |
|
| Stock-based compensation, net of tax (a) |
6,237 |
|
|
$ |
0.09 |
|
|
6,657 |
|
|
$ |
0.10 |
|
| Non-GAAP adjusted net income - excluding stock-based compensation |
$ |
23,531 |
|
|
$ |
0.34 |
|
|
$ |
25,806 |
|
|
$ |
0.38 |
|
| |
|
|
|
|
|
|
|
| Shares used in computing non-GAAP diluted net loss per share |
— |
|
|
68,437 |
|
|
— |
|
|
68,520 |
|
| |
|
|
|
|
|
|
|
| (a) The tax rate represents the effective tax rate on
non-GAAP taxable ordinary income. We expanded our disclosure to correct and clarify the after tax impact of stock-based
compensation on Non-GAAP adjusted net income and diluted EPS. For additional information on the impact of this correction on
prior periods, please refer to the conference call presentation included in Investor Relations section of the Brooks website at
www.brooks.com. |
| |
Quarter
Ended |
| |
June 30,
2016 |
|
March 31, 2016 |
|
June 30, 2015 |
| Dollars in thousands |
$ |
|
% |
|
$ |
|
% |
|
$ |
|
% |
| GAAP gross profit/gross margin percentage |
$ |
54,163 |
|
|
36.7 |
% |
|
$ |
46,800 |
|
|
34.6 |
% |
|
$ |
51,187 |
|
|
35.3 |
% |
| Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
| Amortization of intangible assets |
1,083 |
|
|
0.7 |
% |
|
718 |
|
|
0.5 |
% |
|
1,299 |
|
|
0.9 |
% |
| Purchase accounting impact on inventory and contracts acquired |
125 |
|
|
0.1 |
% |
|
250 |
|
|
0.2 |
% |
|
— |
|
|
— |
|
| Non-GAAP adjusted gross profit/gross margin percentage |
$ |
55,371 |
|
|
37.5 |
% |
|
$ |
47,768 |
|
|
35.3 |
% |
|
$ |
52,486 |
|
|
36.2 |
% |
| |
Nine Months
Ended |
| |
June 30,
2016 |
|
June 30, 2015 |
| Dollars in thousands |
$ |
|
% |
|
$ |
|
% |
| GAAP gross profit/gross margin percentage |
$ |
141,517 |
|
|
35.1 |
% |
|
$ |
136,300 |
|
|
33.5 |
% |
| Adjustments: |
|
|
|
|
|
|
|
| Amortization of intangible assets |
3,097 |
|
|
0.8 |
% |
|
3,903 |
|
|
1.0 |
% |
| Purchase accounting impact on inventory and contracts acquired |
499 |
|
|
0.1 |
% |
|
1,511 |
|
|
0.4 |
% |
| Non-GAAP adjusted gross profit/gross margin percentage |
$ |
145,113 |
|
|
36.0 |
% |
|
$ |
141,714 |
|
|
34.8 |
% |
| |
Quarter
Ended |
|
Nine Months
Ended |
| |
June 30, |
|
March 31, |
|
June 30, |
|
June 30, |
|
June 30, |
| Dollars in thousands |
2016 |
|
2016 |
|
2015 |
|
2016 |
|
2015 |
| GAAP net (loss) income |
$ |
8,564 |
|
|
$ |
(83,939 |
) |
|
$ |
7,681 |
|
|
$ |
(80,022 |
) |
|
$ |
7,658 |
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
| Less: Interest income |
(55 |
) |
|
(50 |
) |
|
(199 |
) |
|
(310 |
) |
|
(678 |
) |
| Add: Interest expense |
37 |
|
|
16 |
|
|
100 |
|
|
56 |
|
|
300 |
|
| Add: Income tax provision (benefit) |
220 |
|
|
78,220 |
|
|
3,340 |
|
|
75,070 |
|
|
1,790 |
|
| Add: Depreciation |
3,633 |
|
|
3,596 |
|
|
2,979 |
|
|
10,167 |
|
|
9,281 |
|
| Add: Amortization of completed technology |
1,083 |
|
|
718 |
|
|
1,299 |
|
|
3,097 |
|
|
3,903 |
|
| Add: Amortization of customer relationships and acquired intangible assets |
2,754 |
|
|
3,091 |
|
|
1,917 |
|
|
8,056 |
|
|
5,743 |
|
| Earnings (losses) before interest, taxes, depreciation and amortization |
$ |
16,236 |
|
|
$ |
1,652 |
|
|
$ |
17,117 |
|
|
$ |
16,114 |
|
|
$ |
27,997 |
|
| |
Quarter
Ended |
|
Nine Months
Ended |
| |
June 30, |
|
March 31, |
|
June 30, |
|
June 30, |
|
June 30 |
| Dollars in thousands |
2016 |
|
2016 |
|
2015 |
|
2016 |
|
2015 |
| Earnings (losses) before interest, taxes, depreciation and amortization |
$ |
16,236 |
|
|
$ |
1,652 |
|
|
$ |
17,117 |
|
|
$ |
16,112 |
|
|
$ |
27,997 |
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
| Add: Stock-based compensation |
1,637 |
|
|
1,855 |
|
|
2,402 |
|
|
8,206 |
|
|
9,510 |
|
| Add: Restructuring charges |
996 |
|
|
7,336 |
|
|
358 |
|
|
9,807 |
|
|
3,711 |
|
| Add: Purchase accounting impact on inventory and contracts acquired |
125 |
|
|
250 |
|
|
— |
|
|
499 |
|
|
1,511 |
|
| Less: Gain on sale of a building |
(55 |
) |
|
— |
|
|
— |
|
|
(55 |
) |
|
— |
|
| Add: Liquidation of a joint venture |
— |
|
|
— |
|
|
69 |
|
|
— |
|
|
69 |
|
| Add: Merger costs |
84 |
|
|
215 |
|
|
44 |
|
|
3,295 |
|
|
432 |
|
| Add: Impairment of equity method investments |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
681 |
|
| Adjusted earnings before interest, taxes, depreciation and amortization |
$ |
19,023 |
|
|
$ |
11,308 |
|
|
$ |
19,990 |
|
|
$ |
37,864 |
|
|
$ |
43,911 |
|
| |
Quarter
Ended |
|
Nine Months
Ended |
| |
June 30, |
|
March 31, |
|
June 30, |
|
June 30, |
|
June 30, |
| Dollars in thousands |
2016 |
|
2016 |
|
2015 |
|
2016 |
|
2015 |
| GAAP selling, general and administrative expenses |
$ |
31,854 |
|
|
$ |
32,692 |
|
|
$ |
27,825 |
|
|
$ |
98,667 |
|
|
$ |
86,845 |
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
| Less: Amortization of customer relationships and acquired intangible assets |
(2,754 |
) |
|
(3,091 |
) |
|
(1,917 |
) |
|
(8,056 |
) |
|
(5,743 |
) |
| Less: Merger costs |
(84 |
) |
|
(215 |
) |
|
(44 |
) |
|
(3,295 |
) |
|
(432 |
) |
| Non-GAAP adjusted selling, general and administrative expenses |
$ |
29,016 |
|
|
$ |
29,386 |
|
|
$ |
25,864 |
|
|
$ |
87,316 |
|
|
$ |
80,670 |
|
| Research and development expenses |
$ |
12,819 |
|
|
$ |
13,111 |
|
|
$ |
12,834 |
|
|
$ |
39,208 |
|
|
$ |
39,001 |
|
| Non-GAAP adjusted operating expenses |
$ |
41,835 |
|
|
$ |
42,497 |
|
|
$ |
38,698 |
|
|
$ |
126,524 |
|
|
$ |
119,671 |
|
| |
Brooks Semiconductor
Solutions Group |
|
Brooks Life Science
Systems |
| |
Quarter
Ended |
|
Quarter
Ended |
| Dollars in thousands |
June 30,
2016 |
|
March 31, 2016 |
|
June 30, 2015 |
|
June 30,
2016 |
|
March 31, 2016 |
|
June 30, 2015 |
| GAAP gross profit |
$ |
42,904 |
|
|
$ |
36,943 |
|
|
$ |
46,515 |
|
|
$ |
11,259 |
|
|
$ |
9,857 |
|
|
$ |
4,672 |
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
| Amortization of intangible assets |
711 |
|
|
390 |
|
|
901 |
|
|
372 |
|
|
328 |
|
|
398 |
|
| Purchase accounting impact on inventory and contracts acquired |
125 |
|
|
250 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
| Non-GAAP adjusted gross profit |
$ |
43,740 |
|
|
$ |
37,583 |
|
|
$ |
47,416 |
|
|
$ |
11,631 |
|
|
$ |
10,185 |
|
|
$ |
5,070 |
|
| |
Brooks Semiconductor
Solutions Group |
|
Brooks Life Science
Systems |
| |
Nine Month
Ended |
|
Nine Month
Ended |
| Dollars in thousands |
June 30,
2016 |
|
June 30, 2015 |
|
June 30,
2016 |
|
June 30, 2015 |
| GAAP gross profit |
$ |
114,506 |
|
|
$ |
122,938 |
|
|
$ |
27,011 |
|
|
$ |
13,362 |
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
| Amortization of intangible assets |
2,005 |
|
|
2,706 |
|
|
1,093 |
|
|
1,197 |
|
| Purchase accounting impact on inventory and contracts acquired |
500 |
|
|
551 |
|
|
— |
|
|
960 |
|
| Non-GAAP adjusted gross profit |
$ |
117,011 |
|
|
$ |
126,195 |
|
|
$ |
28,104 |
|
|
$ |
15,519 |
|
| |
Brooks Semiconductor
Solutions Group |
|
Brooks Life Science
Systems |
| |
Quarter
Ended |
|
Quarter
Ended |
| Dollars in thousands |
June 30,
2016 |
|
March 31, 2016 |
|
June 30, 2015 |
|
June 30,
2016 |
|
March 31,
2016 |
|
June 31,
2015 |
| GAAP gross margin |
36.2 |
% |
|
33.9 |
% |
|
36.3 |
% |
|
38.7 |
% |
|
37.2 |
% |
|
27.8 |
% |
| Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
| Amortization of intangible assets |
0.6 |
% |
|
0.4 |
% |
|
0.7 |
% |
|
1.3 |
% |
|
1.2 |
% |
|
2.4 |
% |
| Purchase accounting impact on inventory and contracts acquired |
0.1 |
% |
|
0.2 |
% |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
| Non-GAAP adjusted gross margin |
36.9 |
% |
|
34.5 |
% |
|
37 |
% |
|
40.0 |
% |
|
38.5 |
% |
|
30.2 |
% |
| |
Brooks Semiconductor
Solutions Group |
|
Brooks Life Science
Systems |
| |
Nine Month
Ended |
|
Nine Month
Ended |
| Dollars in thousands |
June 30,
2016 |
|
June 30, 2015 |
|
June 30,
2016 |
|
June 30,
2015 |
| GAAP gross margin |
35.1 |
% |
|
34.5 |
% |
|
35.3 |
% |
|
26.2 |
% |
| Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
| Amortization of intangible assets |
0.6 |
% |
|
0.8 |
% |
|
1.4 |
% |
|
2.3 |
% |
| Purchase accounting impact on inventory and contracts acquired |
0.2 |
% |
|
0.2 |
% |
|
— |
|
|
1.9 |
% |
| Non-GAAP adjusted gross margin |
35.9 |
% |
|
35.5 |
% |
|
36.8 |
% |
|
30.4 |
% |
